Status:
UNKNOWN
The Frequency of Central Sensitization in Patients With Chronic Musculoskeletal Pain
Lead Sponsor:
Marmara University
Conditions:
Central Sensitisation
Chronic Musculoskeletal Disease
Eligibility:
All Genders
18-75 years
Brief Summary
Central sensitization is as increased response to normal or sub-threshold stimuli of central nervous system and its close relationship with in many musculoskeletal diseases with chronic pain has been ...
Detailed Description
The term central sensitization (CS) was first used in 1988 and was explained as the increase in pain sensitivity with the amplification of neuron-derived signals in the central nervous system. With th...
Eligibility Criteria
Inclusion
- Have musculoskeletal pain that lasts for at least 3 months
- Accepting to participate in the study
Exclusion
- Have rheumatic disease
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04765280
Start Date
January 1 2021
End Date
March 30 2023
Last Update
January 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Feyza Nur YUCEL
Sinop, Turkey (Türkiye), 57200